CIK 0001827635
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Veradermics, Inc
Sign in to watch- Ticker
- MANE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843304423
- Phone
- +1 228-372-3376
- Business address
- 470 JAMES STREET, NEW HAVEN, CT, 06513
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $150,380,000
- in 2 filings
Net −$150,380,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | ENRIGHT PATRICK G Director | Sale | −250,000 | $150.38 | $37.6M | 2,350,399 |
| 2026-11-11 | ENRIGHT PATRICK G Director | Sale | −250,000 | $150.38 | $37.6M | 1,803,474 |
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion | +1,236,631 | 1,236,631 | ||
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion | +1,171,121 | 2,407,752 | ||
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion | +1,171,121 | 1,171,121 | ||
| 2026-02-05 | ENRIGHT PATRICK G Director | Purchase | +192,647 | $17.00 | $3.3M | 2,600,399 |
| 2026-02-05 | ENRIGHT PATRICK G Director | Purchase | +882,353 | $17.00 | $15.0M | 2,053,474 |
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion · Series B Convertible Preferred Stock | −1,236,631 | 0 | ||
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion · Series C Convertible Preferred Stock | −1,171,121 | 0 | ||
| 2026-02-05 | ENRIGHT PATRICK G Director | Conversion · Series C Convertible Preferred Stock | −1,171,121 | 0 | ||
| 2026-02-03 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +45,131 | 45,131 |
Page 1 of 1 · 11 trades